All Stories

  1. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  2. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  3. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  4. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  5. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  6. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  7. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  8. Nose Gym: An Interactive Smell Training Solution
  9. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  10. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  11. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  12. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  13. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  14. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  15. The EUFOREA pocket guide for chronic rhinosinusitis
  16. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  17. Investigations and Outcomes for Olfactory Disorders
  18. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  19. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  20. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  21. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  22. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  23. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  24. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  25. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  26. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  27. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  28. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  29. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  30. International consensus statement on allergy and rhinology: Olfaction
  31. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  32. Interventions for the treatment of persistent post-viral olfactory dysfunction
  33. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  34. Olfaction and CSF Leak
  35. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  36. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  37. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  38. Barriers to effective health care for patients who have smell or taste disorders
  39. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  40. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  41. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  42. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  43. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  44. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  45. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  46. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  47. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  48. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  49. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  50. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  51. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  52. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  53. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  54. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  55. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  56. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  57. Patient Experiences of Postinfectious Olfactory Dysfunction
  58. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  59. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  60. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  61. Comparison of COVID-19 and common cold chemosensory dysfunction
  62. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  63. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  64. Patient Experiences of Post-Infectious Olfactory Dysfunction
  65. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  66. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  67. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  68. Olfactory Loss of Function as a Possible Symptom of COVID-19
  69. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  70. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  71. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  72. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  73. Qualitative Olfactory Disorders: Patient experiences and self-management
  74. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  75. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  76. Parosmia is associated with relevant olfactory recovery after olfactory training
  77. The impact of patients losing their sense of smell
  78. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  79. Cholesteatoma and family history: An international survey
  80. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  81. Biologics for chronic rhinosinusitis
  82. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  83. Biologics for chronic rhinosinusitis
  84. An unmet need: Patients with smell and taste disorders
  85. 139 Risk of parkinson’s in idiopathic anosmia
  86. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  87. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  88. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  89. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  90. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  91. What is the most appropriate treatment for chronic rhinosinusitis?
  92. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  93. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  94. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  95. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  96. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  97. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  98. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  99. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  100. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  101. Wooden spatula sinusitis following maxillary expansion surgery
  102. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  103. Topical and systemic antifungal therapy for chronic rhinosinusitis
  104. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  105. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  106. Saline irrigation for allergic rhinitis
  107. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  108. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  109. Endonasal Approaches to Maxillary Sinus
  110. The use of nasal sprays and rinses in patients with chronic sinus disease
  111. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  112. Initial assessment in the management of adult epistaxis: systematic review
  113. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  114. Health care usage and quality of life reporting in chronic sinusitis patients
  115. The genetics of cholesteatoma. A systematic review using narrative synthesis
  116. Position paper on olfactory dysfunction
  117. Chronic rhinosinusitis and mood disturbance
  118. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  119. Saline irrigation for allergic rhinitis
  120. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  121. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  122. Position paper on olfactory dysfunction
  123. Chronic rhinosinusitis and mood disturbance
  124. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  125. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  126. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  127. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  128. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  129. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  130. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  131. Topical and systemic antifungal therapy for chronic rhinosinusitis
  132. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  133. SNOT-22 in a control population
  134. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  135. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  136. Genetics of Cholesteatoma Project
  137. Short-course oral steroids alone for chronic rhinosinusitis
  138. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  139. Different types of intranasal steroids for chronic rhinosinusitis
  140. Systemic and topical antibiotics for chronic rhinosinusitis
  141. Saline irrigation for chronic rhinosinusitis
  142. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  143. Chronic rhinosinusitis and mood disturbance
  144. Long term quality of life in patients with fungal sinus disease
  145. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  146. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  147. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  148. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  149. Systemic and topical antibiotics for chronic rhinosinusitis
  150. Saline irrigation for chronic rhinosinusitis
  151. Different types of intranasal steroids for chronic rhinosinusitis
  152. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  153. Short-course oral steroids alone for chronic rhinosinusitis
  154. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  155. The impact of commissioning for rhinosinusitis in England
  156. Investigation of nasal diseases
  157. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  158. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  159. Hyposmia
  160. Assessing the sense of smell
  161. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  162. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  163. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  164. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  165. The Impact of Olfactory Disorders in the United Kingdom
  166. Chronic Rhinosinusitis and Mood Disturbance
  167. Management of CRSwNPs Surgically
  168. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  169. SNOT-22 in a Control Population
  170. Anatomy and Physiology of the Olfactory and Gustatory Systems
  171. Cerebrospinal Fluid Rhinorrhoea
  172. Ciliary Motility Disorders
  173. Clinical Governance and Audit
  174. Complications of Sinusitis
  175. Endoscopic Sinus Surgery and Complications
  176. Epistaxis
  177. European Position Paper on Rhinosinusitis and Nasal Polyps
  178. Facial Flaps, Scars, and Keloids
  179. Facial Fractures and Swelling
  180. Fungal Sinus Disease
  181. Headache and Facial Pain
  182. Medical Statistics
  183. Microbiology of ENT
  184. Olfactory and Gustatory Disorders
  185. Sinonasal Anatomy and Physiology
  186. Tumours of the Nose and Paranasal Sinuses
  187. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  188. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  189. Unilateral cacosmia: a presentation of maxillary fungal infestation
  190. When mealtime is the most dreaded moment of your day
  191. Pneumatisation of turbinates and paranasal sinuses in children: case report
  192. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  193. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  194. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  195. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  196. A useful tool - systematic checklist for evaluating sinus scans
  197. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  198. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  199. Allergic fungal rhinosinusitis - a new staging system
  200. Allergic fungal rhinosinusitis - a new staging system
  201. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  202. Selecting the Best Approach to the Frontal Sinus
  203. Nanomedicine in otorhinolaryngology: what does the future hold?
  204. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  205. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  206. Tumefactive fibroinflammatory lesion of the frontal sinus
  207. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  208. SUBJECTS AND METHODS
  209. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  210. Proximal Lacrimal Obstruction – A Review
  211. The superosmic phenomenon
  212. The Leicester Olfactometer
  213. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  214. ENT cases seen at a local ‘walk-in centre’: a one year review
  215. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  216. A brief history of olfaction and olfactometry
  217. The superosmic phenomenon
  218. Olfactory clearance: what time is needed in clinical practice?
  219. The Effect of Female Hormone Manipulation on Nasal Physiology
  220. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  221. R152: Olfactory Adaptation and Clearance in Clinical Practice
  222. Bronchiectasis and sino-nasal disease: a review
  223. What is the short term effect of perfumes on olfactory thresholds?
  224. Which variables matter in smell tests in the clinic?
  225. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  226. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  227. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  228. Comparison of Subjective Perception with Objective Measurement of Olfaction
  229. Response to Rachmanidou
  230. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  231. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  232. Do our Noses Lead Us Away from the Scent?
  233. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  234. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  235. Is there a role for more day-case septal surgery?
  236. Erratum
  237. Canalicular adenoma of the parotid gland
  238. Paediatric retropharyngeal abscess
  239. Which solvent for olfactory testing?
  240. Nasal physiological changes during pregnancy
  241. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  242. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  243. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  244. Subjects and methods
  245. Hyposmia